Successful treatment of acute portal vein thrombosis with rivaroxaban.


doi:10.1160/TH13-05-0407 Thromb Haemost 2013; 110: 626–627 Splanchnic vein thrombosis (SVT) is a potentially life-threatening disease (1) and anticoagulant therapy with low-molecularweight heparin or vitamin K antagonists is recommended (2). However, these agents lack evidence from randomised prospective trials, are not specifically approved and have… (More)
DOI: 10.1160/TH13-05-0407


1 Figure or Table

Cite this paper

@article{Pannach2013SuccessfulTO, title={Successful treatment of acute portal vein thrombosis with rivaroxaban.}, author={Sven Pannach and Jana Babatz and Jan Beyer-Westendorf}, journal={Thrombosis and haemostasis}, year={2013}, volume={110 4}, pages={626-7} }